These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34806799)

  • 21. Progression of grey and white matter brain damage in Parkinson's disease: a critical review of structural MRI literature.
    Sarasso E; Agosta F; Piramide N; Filippi M
    J Neurol; 2021 Sep; 268(9):3144-3179. PubMed ID: 32378035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct white matter microstructural abnormalities and extracellular water increases relate to cognitive impairment in Alzheimer's disease with and without cerebrovascular disease.
    Ji F; Pasternak O; Liu S; Loke YM; Choo BL; Hilal S; Xu X; Ikram MK; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2017 Aug; 9(1):63. PubMed ID: 28818116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia.
    Dadar M; Manera AL; Ducharme S; Collins DL
    Neurobiol Aging; 2022 Mar; 111():54-63. PubMed ID: 34968832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. White matter hyperintensities and the surrounding normal appearing white matter are associated with water channel disruption in the oldest old.
    Silbert LC; Roese NE; Krajbich V; Hurworth J; Lahna D; Schwartz DL; Dodge HH; Woltjer RL
    Alzheimers Dement; 2024 Jun; 20(6):3839-3851. PubMed ID: 38629888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.
    Chondrogiorgi M; Astrakas LG; Zikou AK; Weis L; Xydis VG; Antonini A; Argyropoulou MI; Konitsiotis S
    Brain Imaging Behav; 2019 Feb; 13(1):232-240. PubMed ID: 29629498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. White Matter Microstructural Underpinnings of Mild Behavioral Impairment in Parkinson's Disease.
    Monchi O; Pinilla-Monsalve GD; Almgren H; Ghahremani M; Kibreab M; Maarouf N; Kathol I; Boré A; Rheault F; Descoteaux M; Ismail Z
    Mov Disord; 2024 Jun; 39(6):1026-1036. PubMed ID: 38661496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is white matter hyperintensity burden associated with cognitive and motor impairment in patients with parkinson's disease? A systematic review and meta-analysis.
    Carvalho de Abreu DC; Pieruccini-Faria F; Son S; Montero-Odasso M; Camicioli R
    Neurosci Biobehav Rev; 2024 Jun; 161():105677. PubMed ID: 38636832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of homocysteine, folate, and white matter hyperintensities in Parkinson's patients with different motor phenotypes.
    Shen Y; Dong ZF; Pan PL; Xu G; Huang JY; Liu CF
    Neurol Sci; 2019 Sep; 40(9):1855-1863. PubMed ID: 31055730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
    Chahine LM; Dos Santos C; Fullard M; Scordia C; Weintraub D; Erus G; Rosenthal L; Davatzikos C; McMillan CT
    Eur J Neurol; 2019 Feb; 26(2):246-e18. PubMed ID: 30169897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hierarchical cluster analysis of multimodal imaging data identifies brain atrophy and cognitive patterns in Parkinson's disease.
    Inguanzo A; Sala-Llonch R; Segura B; Erostarbe H; Abos A; Campabadal A; Uribe C; Baggio HC; Compta Y; Marti MJ; Valldeoriola F; Bargallo N; Junque C
    Parkinsonism Relat Disord; 2021 Jan; 82():16-23. PubMed ID: 33227683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myelin loss in white matter hyperintensities and normal-appearing white matter of cognitively impaired patients: a quantitative synthetic magnetic resonance imaging study.
    Park M; Moon Y; Han SH; Kim HK; Moon WJ
    Eur Radiol; 2019 Sep; 29(9):4914-4921. PubMed ID: 30488109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. R2* relaxometry analysis for mapping of white matter alteration in Parkinson's disease with mild cognitive impairment.
    Kan H; Uchida Y; Ueki Y; Arai N; Tsubokura S; Kunitomo H; Kasai H; Aoyama K; Matsukawa N; Shibamoto Y
    Neuroimage Clin; 2022; 33():102938. PubMed ID: 34998126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Association of age-related white matter hyperintensity with brain atrophy and cognitive impairment in patients with Parkinson's disease].
    Chen HM; Zhang MM; Wang YL
    Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(43):3397-3401. PubMed ID: 33238668
    [No Abstract]   [Full Text] [Related]  

  • 35. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P; Pagani E; Morelli ME; Copetti M; Martinelli V; Pirro F; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebral small vessel disease affects white matter microstructure in mild cognitive impairment.
    Papma JM; de Groot M; de Koning I; Mattace-Raso FU; van der Lugt A; Vernooij MW; Niessen WJ; van Swieten JC; Koudstaal PJ; Prins ND; Smits M
    Hum Brain Mapp; 2014 Jun; 35(6):2836-51. PubMed ID: 24115179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. White Matter Integrity in Subcortical Vascular Cognitive Impairment: A Multimodal Structural MRI Study.
    Wang Y; Cao W; Sun Y; Chen X; Ding W; Xu Q; Zhou Y; Xu J; Suo S
    Curr Alzheimer Res; 2017; 14(9):991-999. PubMed ID: 28356046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tracking Cortical Changes Throughout Cognitive Decline in Parkinson's Disease.
    Filippi M; Canu E; Donzuso G; Stojkovic T; Basaia S; Stankovic I; Tomic A; Markovic V; Petrovic I; Stefanova E; Kostic VS; Agosta F
    Mov Disord; 2020 Nov; 35(11):1987-1998. PubMed ID: 32886420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced [
    Moscoso A; Grothe MJ; Schöll M;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2283-2294. PubMed ID: 33475761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
    Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
    Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.